abc biopply ag

abc biopply is a CRO with its own specifically designed proprietary 3D cell culture platform 3D CoSeedis™. The company is specialized in advanced solutions for preclinical disease models and drug discovery. Since its foundation in 2017, abc biopply has pioneered a unique portfolio of 3D tissue imaging and analysis assays all based on the groundbreaking flexibility of our 3D CoSeedis ™ Co-Culture System, enabling the easy and reliable generation of quantitative datasets from tissues and cells. abc biopply offers a wide range of assay formats and downstream endpoints. To learn more about the range of assays we provide, or to explore our portfolio of 3D products and protocols to support your in-house applications please reach out to discuss how we can enhance your research.